The Escalating Role of Epidermal Growth Factor Receptor Inhibitors in Cancer Management: Clinical Considerations for the Health System Pharmacist

समान संसाधन

• The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
  द्वारा: Witold Owczarek, और अन्य
  प्रकाशित: (2017-10-01)
• Management of diarrhea induced by epidermal growth factor receptor tyrosine kinase inhibitors
  द्वारा: Hirsh, V., और अन्य
  प्रकाशित: (2014)
• The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
  द्वारा: Owczarek, Witold, और अन्य
  प्रकाशित: (2017)
• Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
  द्वारा: Chanprapaph, K., और अन्य
  प्रकाशित: (2014)
• Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer
  द्वारा: Chan, David Lok Hang, और अन्य
  प्रकाशित: (2017)